Immune Design Corp buy melinda
Start price
15.03.17
/
50%
€5.77
Target price
17.03.17
€6.31
Performance (%)
10.16%
End price
17.03.17
€6.36
Summary
This prediction ended on 17.03.17 with a price of €6.36. The BUY prediction by melinda finished with a performance of 10.16%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immune Design Corp | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by melinda for this prediction
In the thread Immune Design Corp diskutieren
Tumoren
CMB305
Krebs - soliden Tumoren
Stopped prediction by melinda for Immune Design Corp
Immune Design Corp
Start price
Target price
Perf. (%)
€4.56
01.11.17
01.11.17
€9.92
19.12.17
19.12.17
-23.27%
19.12.17
19.12.17
